Carbon announced that its developmental bioabsorbable elastomer platform has demonstrated biocompatibility in vivo, with all samples being classified as non-toxic and exhibiting tunable times for full absorption. This latest milestone demonstrated the elastomer’s potential in biomedical applications such as soft tissue repair, wound dressings, and nerve conduits. Carbon’s developmental bioabsorbable elastomer, created with Digital Light
The first genomics analysis of congenital heart disease has improved our understanding of the mechanisms underlying the progression of the condition and revealed opportunities for personalized treatments.
Harold Jean never knew that he was born with a heart condition. He lived a normal childhood, played sports, and exercised. But in 2005, at the age of 23, he